Multi-tasking to Hyper-tasking: Investigating the Impact of Next Generation 911 (NG911)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02961621 |
Recruitment Status :
Completed
First Posted : November 11, 2016
Last Update Posted : May 11, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Emergency call centers across the country are preparing for the Next Generation 911 (NG911) initiative, which will allow citizens to place 9-1-1 "calls" using digital technologies such as text messaging, email, Skype or instant messaging, and will expand emergency information sources to also include streaming video, photo uploads, and automatic crash notifications. The impact of these new information and communication technologies on those tasked with using them in time-sensitive emergency situations is unknown. Our study is designed to address the following hypotheses: 1) We hypothesize that NG911 implementation will have a significant effect on telecommunicator stress levels and 2) A resiliency training tailored to the needs of telecommunicators will mitigate the impact on NG911 implementation on stress levels. We will test these hypotheses through the following specific aims:
Aim 1: Measure levels of stress, job satisfaction and job performance among 9-1-1 telecommunicators before and after the NG911 implementation.
Aim 2: Develop and test the efficacy of an evidence-based resiliency training and worker support intervention to improve psychological well-being and job performance of 9-1-1 telecommunicators.
Aim 3: Build an ABM tool of 9-1-1 call centers to improve 9-1-1 telecommunicator workforce training and smooth transitions to future call center innovations.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stress, Psychological | Behavioral: Stress Reduction Training for 9-1-1 Telecommunicators | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 323 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Multi-tasking to Hyper-tasking: Investigating the Impact of Next Generation 911 |
Study Start Date : | May 1, 2015 |
Actual Primary Completion Date : | November 1, 2017 |
Actual Study Completion Date : | December 15, 2017 |
Arm | Intervention/treatment |
---|---|
Experimental: Stress Reduction Training Group
This group will complete a 7-week online mindfulness-based resiliency training: Stress Reduction Training for 9-1-1 Telecommunicators
|
Behavioral: Stress Reduction Training for 9-1-1 Telecommunicators |
No Intervention: Control Group
This group is a wait-list control and will be offered the training after all data collection has been completed.
|
- Calgary Symptoms of Stress Inventory [ Time Frame: Baseline, immediately post intervention and 3 months post intervention ]Change in the Calgary Symptoms of Stress Inventory results

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- subjects must be 9-1-1 telecommunicators (call receivers and dispatchers) who work at participating call centers and consent to participate.
Exclusion Criteria:
- We will exclude subjects who do not consent to participate
- We will exclude subjects who do not confirm that they are 21 or older.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02961621
Principal Investigator: | Hendrika Meischke, PhD, MPH | University of Washington |
Responsible Party: | Hendrika Meischke, Professor, University of Washington |
ClinicalTrials.gov Identifier: | NCT02961621 |
Other Study ID Numbers: |
STUDY00001920 |
First Posted: | November 11, 2016 Key Record Dates |
Last Update Posted: | May 11, 2018 |
Last Verified: | May 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Stress, Psychological Behavioral Symptoms |